Liver Cancer clinical trials in Kansas

8 actively recruiting liver cancer trials at 5 sites across Kansas.

Data from ClinicalTrials.gov · last refreshed 2026-04-20

Phase 2, Phase 3 Recruiting Industry

A Study to Assess the Dose, Adverse Events, and Change in Disease Activity of Livmoniplimab as an Intravenous (IV) Solution in Combination With Budigalimab as an IV Solution in Adult Participants With Hepatocellular Carcinoma (HCC)

Hepatocellular carcinoma (HCC) is a common cancer worldwide and a leading cause of cancer-related death. The majority of participants first presenting with HCC have advanced unresectable or metastatic disease. The purpose of this study is …

Sponsor: AbbVie

NCT ID: NCT06109272

Sites in Kansas:

Alliance for Multispecialty Research LLC Kansas City Oncology /ID# 256830 — Merriam, Kansas

View on ClinicalTrials.gov →

Phase 2 Recruiting NIH

Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery

This phase II trial tests how well giving durvalumab with standard chemotherapy, gemcitabine and cisplatin, before surgery works in treating patients with high risk liver cancer (cholangiocarcinoma) that can be removed by surgery (resectab…

Sponsor: National Cancer Institute (NCI)

NCT ID: NCT06050252

Sites in Kansas:

University of Kansas Clinical Research Center — Fairway, Kansas
University of Kansas Cancer Center — Kansas City, Kansas
University of Kansas Cancer Center-Overland Park — Overland Park, Kansas
University of Kansas Hospital-Westwood Cancer Center — Westwood, Kansas

View on ClinicalTrials.gov →

Phase 2 Recruiting Industry

Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer

GEMINI-Hepatobiliary study will assess the efficacy, safety and tolerability of novel immunomodulators alone and in combination with other anticancer drugs in participants with specified advanced solid tumors.

Sponsor: AstraZeneca

NCT ID: NCT05775159

Sites in Kansas:

Research Site — Kansas City, Kansas

View on ClinicalTrials.gov →

Phase 1, Phase 2 Recruiting Industry

T-Cell Therapy (ECT204) in Adults With Advanced HCC

This is an open-label, dose escalation, multi-center, Phase I/II clinical trial aimed at assessing the safety and preliminary efficacy of an investigational ARTEMIS® ECT204 T-cell therapy. The trial is suitable for adult subjects (≥ 18 yea…

Sponsor: Eureka Therapeutics Inc.

NCT ID: NCT04864054

Sites in Kansas:

Kansas University Medical Center, Principal Investigator: — Westwood, Kansas

View on ClinicalTrials.gov →

Phase 1, Phase 2 Recruiting Academic/Other

Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies

The investigators propose to evaluate the safety of drug combinations in patients with advanced gastroesophageal cancer and other gastrointestinal (GI) malignancies. Finding effective novel therapies for patients with advanced gastric canc…

Sponsor: Anwaar Saeed

NCT ID: NCT03539822

Sites in Kansas:

University of Kansas Cancer Center — Westwood, Kansas

View on ClinicalTrials.gov →

Phase 1 Recruiting Industry

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

A Phase 1 study to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamic (PD), and preliminary antitumor activity of TYRA-430 in cancers with FGF/FGFR pathway aberrations, including locally advanced/metastatic hepatocel…

Sponsor: Tyra Biosciences, Inc

NCT ID: NCT06915753

Sites in Kansas:

The University of Kansas Medical Center — Westwood, Kansas

View on ClinicalTrials.gov →

Recruiting Academic/Other

Integrated Cancer Repository for Cancer Research

The iCaRe2 is a multi-institutional resource created and maintained by the Fred \& Pamela Buffett Cancer Center to collect and manage standardized, multi-dimensional, longitudinal data and biospecimens on consented adult cancer patients, h…

Sponsor: University of Nebraska

NCT ID: NCT02012699

Sites in Kansas:

Saint Luke's Cancer Instititute - South — Overland Park, Kansas

View on ClinicalTrials.gov →

NA Recruiting Academic/Other

vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC

This trial will provide the maximum tolerated dose for radiation therapy for liver tumors and describe the toxicity profile using the vGRID therapy technique. Based on trials using this type of radiation in other cancers demonstrating low …

Sponsor: University of Kansas Medical Center

NCT ID: NCT05727787

Sites in Kansas:

University of Kansas Medical Center — Kansas City, Kansas

View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-04-20